stockrowAnaptysBio, Inc. (ANAB) vs Mineralys Therapeutics, Inc. (MLYS)
- AnaptysBio, Inc. ANAB 46.43 +1.86%
- Mineralys Therapeutics, Inc. MLYS 15.35 +0.72%
AnaptysBio, Inc. and Mineralys Therapeutics, Inc. are both Biotechnology companies. AnaptysBio, Inc. and Mineralys Therapeutics, Inc. are of similar size ($1.4B and $1.4B). Mineralys Therapeutics, Inc. has the higher net margin (0.00% vs −11.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, AnaptysBio, Inc. leads on 8 and Mineralys Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | ANAB | MLYS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 68.51% |
| Operating margin | 17.56% | 0.00% | 0.00% |
| Net margin | (11.53%) | 0.00% | 0.00% |
| Free cash flow margin | 1.90% | 0.00% | 0.00% |
| Return on equity | (114.55%) | (80.88%) | (51.96%) |
| Return on assets | (7.13%) | (69.67%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack